How to appeal a UnitedHealthcare sickle cell & thalassemia denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for sickle cell & thalassemia

Cited policy: UHC Medical Policy: Hematopoietic Cell Transplantation for Hemoglobinopathies (Casgevy / Lyfgenia / Zynteglo)

FDA-approved gene therapy at certified ATC. ≥2 severe VOCs in past 12mo (SCD) or transfusion-dependent (TDT). Hydroxyurea max-tolerated trial ≥6mo failed/intolerant. Age 12+. Fertility counseling completed.

How UnitedHealthcare denies sickle cell & thalassemia — and how to counter it

Where UnitedHealthcare pushes back: 1) HU not max-tolerated long enough; 2) VOC threshold (≥4 historically); 3) Out-of-network ATC.

Counter-arguments that hold up: Document HU max-tolerated 35 mg/kg with MCV rise and persistent VOCs. FDA label is 2 VOCs (not 4 — challenge as exceeding label). Cite CLIMB-121 / HGB-206. Request single-case agreement / network gap exception for ATC.

What UnitedHealthcare typically denies for sickle cell & thalassemia

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For sickle cell & thalassemia, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the sickle cell & thalassemia treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Casgevy
• Lyfgenia
• Zynteglo
• Allogeneic HSCT
• Hydroxyurea
• Adakveo

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.